Ceva launches novel vaccine to protect pigs from common respiratory disease

Ceva Santé Animale announced on Thursday that it has launched a new vaccine in Europe to prevent Mycoplasma hyopneumoniae, a bacterial respiratory disease that affects 90% of the world's swine farms. When administered at weaning, the vaccine protects pigs for up to 26 weeks, offering a longer period of protection than most competing products, the company said in a press release. A single shot is designed to keep the animals healthy throughout the fattening period, which will also help farmers cut down on the controversial prophylactic use of antibiotics, the company says. Ceva has also introduced a mobile app to help farmers track bacterial pathogens and target vaccinations according to the needs of individual herds. Release